4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004955
Chief Commercial Officer gave up 5,769 shares (to pay taxes)
- Chief Commercial Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoerter Steven L. Chief Commercial Officer | 2019-01-20 | Option exercise | +15,000 | 15,000 | D | ||
| Hoerter Steven L. Chief Commercial Officer | 2019-01-22 | Shares withheld for taxes | −5,769 | $52.82 | $304,719 | 9,231 | D |
| Derivatives | |||||||
| Hoerter Steven L. Chief Commercial Officer | 2019-01-20 | Option exercise · Performance share unit | −15,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…